Dupont Capital Management Corp Athenex, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$0.79 - $1.59 $91,969 - $185,103	-116,417 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$1.36 - $2.94 $32,214 - $69,639	23,687 Added 25.54%	116,417 $158,000
Q3 2021 Nov 03, 2021	SELL	$2.97 - $4.84 $38,924 - $63,433	-13,106 Reduced 12.38%	92,730 $279,000
Q2 2021 Jul 30, 2021	BUY	$3.71 - $5.13 $392,651 - $542,938	105,836 New	105,836 $489,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.